https://www.biopharmadive.com/news/coronavirus-gilead-remdesivir-orphan-drug/574882/
After sparking controversy, the biotech asked the FDA to rescind a designation designed to encourage research into therapies for rare diseases.
orphan statusraremovegileadgives
https://www.pharmaceutical-technology.com/uncategorized/news129789-html/
The US Food and Drug Administration (FDA) has granted orphan drug designation to Avedro's VibeX (0.1.% riboflavin ophthalmic solution) for use with its KXL...
orphan drug statusfdagrantsavedrovibex
https://www.pharmaceutical-technology.com/news/newsfda-grants-orphan-status-amarantus-eltoprazine-treat-pd-lid-4807378/
The US Food and Drug Administration (FDA) has granted orphan drug designation for Amarantus BioScience Holdings' (AMBS') eltoprazine to treat Parkinson's...
orphan statusfdagrantsamarantuseltoprazine
https://www.newswire.ca/news-releases/biotech-review-dvax-vaccine-faces-crucial-pdufa-date-cldx-seeks-fast-track-orphan-drug-status-597441391.html
/CNW/ - TradersNewsSource.com Biotechnology Market News: Two small-cap biotech companies we follow, Dynavax Technologies Corporation (NASDAQ: DVAX) and...
pdufa datebiotechreviewvaccinefaces
https://www.pharmaceutical-technology.com/uncategorized/newscempras-taksta-secures-fda-orphan-drug-status-prosthetic-joint-infections-treatment/
Clinical-stage pharmaceutical firm Cempra has secured orphan drug status from the US Food and Drug Administration (FDA) for its drug candidate Taksta (CEM-102)...
orphan drug statustakstasecuresfdaprosthetic
https://www.news-medical.net/news/20110908/EC-grants-orphan-drug-status-for-Santens-sirolimus-to-treat-chronic-non-infectious-uveitis.aspx
Santen Inc., the U.S. subsidiary of global ophthalmic pharmaceutical company Santen Pharmaceutical Co., Ltd. today announced the European Commission (EC) has...
orphan drug statusecgrantssantensirolimus
https://www.pharmaceutical-technology.com/news/qbiotics-wins-fda-orphan-status-for-rainforest-derived-cancer-drug/
Though the designation is for soft tissue sarcoma, tigilanol tiglate is in clinical trials for multiple cancer types.
orphan statuscancer drugwinsfdarainforest